Treatment of Neonatal Hypocortisolism
Neonatal hypocortisolism should be treated with hydrocortisone at physiologic replacement doses of 8-15 mg/m²/day divided into 2-3 doses, with the first dose given in the morning (07:00) and subsequent doses at midday and afternoon to mimic the natural cortisol circadian rhythm.
Glucocorticoid Replacement Strategy
The cornerstone of treatment is hydrocortisone replacement therapy, which must be initiated promptly to prevent life-threatening complications and restore normal physiology 1. The dosing regimen should follow these principles:
Dosing Schedule
Three-dose regimen (preferred for optimal circadian mimicry):
- Morning (07:00): 10 mg
- Midday (12:00): 5 mg
- Afternoon (16:00): 2.5-5 mg
- Total daily dose: 15-20 mg for typical neonates 1
Two-dose regimen (acceptable alternative):
- Morning (07:00): 10-15 mg
- Midday (12:00): 5-10 mg 1
Critical Clinical Context
Neonatal cholestasis is an important presentation of hypocortisolism that requires recognition. When congenital pituitary hormone deficiency or isolated central hypocortisolism presents with cholestasis (typically onset at median 18 days of life), hormone replacement therapy leads to complete resolution of cholestasis at approximately 65 days and normalization of liver enzymes by 90 days 2. This underscores the urgency of early diagnosis and treatment.
Mineralocorticoid Replacement
Fludrocortisone (9α-fludrocortisone) is essential for primary adrenal insufficiency but may not be required in isolated central hypocortisolism where the adrenal glands retain mineralocorticoid function 1.
When indicated:
- Dose: 50-200 µg daily (may require up to 500 µg in neonates and young infants)
- Timing: Single morning dose upon awakening
- Monitoring: Assess for salt craving, orthostatic symptoms, blood pressure, and peripheral edema 1
Important Caveats
- Under-replacement of mineralocorticoids is common and sometimes inappropriately compensated by glucocorticoid over-replacement
- Avoid diuretics, acetazolamide, NSAIDs, and liquorice, which interact with fludrocortisone 1
- Unrestricted sodium intake should be encouraged; avoid potassium-containing salt substitutes 1
Special Populations and Considerations
Extremely Preterm Neonates
For extremely low gestational age neonates (ELGANs) with relative adrenal insufficiency presenting with refractory hypotension:
- Prophylactic low-dose hydrocortisone at replacement dosage improves survival without bronchopulmonary dysplasia and facilitates patent ductus arteriosus closure 3
- Hydrocortisone increases blood pressure (effect size r=0.71) and reduces vasopressor requirements (r=0.74) in hypotensive preterm infants 4
- Caution: Avoid combining with indomethacin due to increased risk of spontaneous intestinal perforation; monitor for late-onset sepsis, particularly in 24-25 week gestation infants 3
Transient vs. Permanent Hypocortisolism
Isolated neonatal hypocortisolism may be transient and should be re-evaluated after clinical resolution 2. Do not assume lifelong replacement is necessary without confirmatory testing after the acute phase.
Monitoring and Dose Adjustments
Drug Interactions Requiring Dose Modification
Hydrocortisone requirements increase with:
- Anti-epileptic drugs/barbiturates
- Antituberculosis medications
- Etomidate
- Topiramate 1
Hydrocortisone requirements decrease with:
- Grapefruit juice
- Liquorice (also potentiates mineralocorticoid effects) 1
Clinical Pitfalls to Avoid
- Delayed referral: Median referral to endocrinology occurs at 32 days, but cholestasis presents at 18 days—earlier recognition is critical 2
- Inadequate stress dosing: During illness or procedures, doses must be increased (typically 2-3× maintenance)
- Mineralocorticoid neglect: Under-replacement leads to recurrent adrenal crises 1
- Premature discontinuation: Verify persistent need through formal testing before stopping therapy in cases of suspected transient hypocortisolism 2
Alternative Agents (Not First-Line in Neonates)
Cortisone acetate (25-37.5 mg daily in divided doses) is an alternative but requires hepatic conversion to active cortisol, making it less reliable in neonates with immature liver function or cholestasis 1.
Prednisolone should only be considered for compliance issues or intolerance to hydrocortisone/cortisone acetate, and is generally inappropriate for neonatal physiologic replacement 1.
Dexamethasone showed some efficacy for refractory hypotension in one small study but cannot be recommended for routine use due to lack of long-term safety data in this population 5.